ACNB vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ACNB exhibits weak financial health per the Piotroski F-Score of 2/9, indicating significant operational and financial vulnerabilities. The absence of an Altman Z-Score raises concern about default risk, especially given the lack of disclosed leverage and liquidity metrics. Despite strong profitability (25.26% margin, 41.88% operating margin) and robust revenue and earnings growth (37.6% and 35.0% YoY), the stock trades at a premium to its Graham Number ($57.27) and intrinsic value ($106.2), suggesting overvaluation relative to conservative metrics. Insider selling activity over the past six months and a bearish technical trend further temper optimism, despite a solid dividend payout ratio and recent earnings beats.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
ACNB vs JPM: Head-to-Head Comparison
This page compares ACNB Corporation (ACNB) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.